EP1363703A4 - Prävention von krankheiten durch thymusreaktivierung - Google Patents
Prävention von krankheiten durch thymusreaktivierungInfo
- Publication number
- EP1363703A4 EP1363703A4 EP01986582A EP01986582A EP1363703A4 EP 1363703 A4 EP1363703 A4 EP 1363703A4 EP 01986582 A EP01986582 A EP 01986582A EP 01986582 A EP01986582 A EP 01986582A EP 1363703 A4 EP1363703 A4 EP 1363703A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- reactivation
- thymus
- disease prevention
- disease
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000006806 disease prevention Effects 0.000 title 1
- 230000007420 reactivation Effects 0.000 title 1
- 210000001541 thymus gland Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2046—IL-7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2086—IL-13 to IL-16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/464838—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- AIDS & HIV (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
Applications Claiming Priority (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US755646 | 1985-07-16 | ||
US755965 | 1991-09-06 | ||
US965395 | 1997-11-06 | ||
US79530200A | 2000-10-13 | 2000-10-13 | |
US79528600A | 2000-10-13 | 2000-10-13 | |
AUPR0745A AUPR074500A0 (en) | 2000-10-13 | 2000-10-13 | Treatment of t cell disorders |
AUPR074500 | 2000-10-13 | ||
US795286 | 2000-10-13 | ||
US795302 | 2000-10-13 | ||
US75564601A | 2001-01-05 | 2001-01-05 | |
US75598301A | 2001-01-05 | 2001-01-05 | |
US09/755,965 US20010046486A1 (en) | 2000-04-17 | 2001-01-05 | Stimulation of thymus for vaccination development |
US755983 | 2001-01-05 | ||
US75891001A | 2001-01-10 | 2001-01-10 | |
US758910 | 2001-01-10 | ||
US09/965,395 US20020081276A1 (en) | 1999-04-15 | 2001-09-26 | Disease prevention by reactivation of the thymus |
PCT/IB2001/002745 WO2002030259A2 (en) | 2000-10-13 | 2001-10-12 | Disease prevention by reactivation of the thymus |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1363703A2 EP1363703A2 (de) | 2003-11-26 |
EP1363703A4 true EP1363703A4 (de) | 2006-06-07 |
Family
ID=27570138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01986582A Ceased EP1363703A4 (de) | 2000-10-13 | 2001-10-12 | Prävention von krankheiten durch thymusreaktivierung |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1363703A4 (de) |
CN (1) | CN100406025C (de) |
AP (1) | AP2003002796A0 (de) |
AU (1) | AU1632302A (de) |
BR (1) | BR0114642A (de) |
CA (1) | CA2462681A1 (de) |
IL (1) | IL155414A0 (de) |
NZ (1) | NZ525830A (de) |
WO (1) | WO2002030259A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004103271A2 (en) * | 2003-04-18 | 2004-12-02 | Norwood Immunology, Ltd. | Disease prevention and vaccination prior to thymic reactivations |
WO2009043479A2 (en) * | 2007-09-11 | 2009-04-09 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
US8871191B2 (en) | 2009-08-14 | 2014-10-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of IL-15 preparations to treat lymphopenia |
ES2572329B1 (es) | 2011-10-21 | 2017-08-24 | Abbvie Inc. | Combinación de al menos dos agentes antivirales de acción directa y ribavirina pero no interferón, para uso en el tratamientodel vhc |
US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
BR112014005617A2 (pt) | 2011-10-21 | 2017-06-13 | Abbvie Inc | tratamento de combinação (por exemplo, com abt-072 ou abt -333) de daas para uso no tratamento de hcv |
WO2017189978A1 (en) | 2016-04-28 | 2017-11-02 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4049805A (en) * | 1975-09-30 | 1977-09-20 | Akzona Incorporated | Steroidal erythropoietic agents and therapeutic compositions and methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1058500C (zh) * | 1993-02-03 | 2000-11-15 | 施塞克龙药品公司 | 胸腺素α-1衍生物 |
ATE222111T1 (de) * | 1993-05-17 | 2002-08-15 | Gen Hospital Corp | Ein thymus-fremdtransplantat |
AUPP971499A0 (en) * | 1999-04-12 | 1999-05-06 | Opentec Pty. Limited | On-line electoral system |
AUPP977899A0 (en) * | 1999-04-15 | 1999-05-13 | Monash University | Improvement of t cell mediated immunity |
-
2001
- 2001-10-12 IL IL15541401A patent/IL155414A0/xx unknown
- 2001-10-12 NZ NZ525830A patent/NZ525830A/en unknown
- 2001-10-12 AU AU1632302A patent/AU1632302A/xx active Pending
- 2001-10-12 WO PCT/IB2001/002745 patent/WO2002030259A2/en active IP Right Grant
- 2001-10-12 EP EP01986582A patent/EP1363703A4/de not_active Ceased
- 2001-10-12 AP APAP/P/2003/002796A patent/AP2003002796A0/en unknown
- 2001-10-12 CN CNB018201342A patent/CN100406025C/zh not_active Expired - Fee Related
- 2001-10-12 BR BR0114642-4A patent/BR0114642A/pt not_active IP Right Cessation
- 2001-10-12 CA CA002462681A patent/CA2462681A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4049805A (en) * | 1975-09-30 | 1977-09-20 | Akzona Incorporated | Steroidal erythropoietic agents and therapeutic compositions and methods |
Also Published As
Publication number | Publication date |
---|---|
EP1363703A2 (de) | 2003-11-26 |
AP2003002796A0 (en) | 2003-06-30 |
CN1505537A (zh) | 2004-06-16 |
CN100406025C (zh) | 2008-07-30 |
CA2462681A1 (en) | 2002-04-18 |
WO2002030259A3 (en) | 2002-07-04 |
WO2002030259A9 (en) | 2003-08-07 |
AU1632302A (en) | 2002-04-22 |
BR0114642A (pt) | 2004-01-20 |
NZ525830A (en) | 2005-07-29 |
WO2002030259A2 (en) | 2002-04-18 |
IL155414A0 (en) | 2003-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0023983D0 (en) | Therapeutic compounds | |
GB0008710D0 (en) | Therapeutic compounds | |
GB0016681D0 (en) | Therapeutic compounds | |
IL150742A0 (en) | Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease | |
GB0028583D0 (en) | Therapeutic compounds | |
AU1632302A (en) | Disease prevention by reactivation of the thymus | |
GB9900222D0 (en) | Therapeutic compounds | |
AU8609201A (en) | Reduction of the electrocardiographic ot interval | |
GB0029524D0 (en) | Disease treatment | |
GB0013105D0 (en) | Therapeutic compounds | |
GB9902994D0 (en) | DNM massager | |
TW471276U (en) | Assembly bed | |
TW391252U (en) | Massaging bed | |
TW378683U (en) | Improved structure for the combination floor | |
AU145815S (en) | Lavatory | |
TW378528U (en) | Improved structure for the bowl | |
CA85813S (en) | Walker | |
CA85805S (en) | Walker | |
CA87331S (en) | Lavatory top | |
CA86188S (en) | Lavatory | |
CA86187S (en) | Lavatory | |
GB9923465D0 (en) | Double doggy walker | |
GB0022347D0 (en) | Therapeutic compounds | |
GB0023984D0 (en) | Therapeutic compounds | |
GB0023982D0 (en) | Therapeutic Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030513 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1061366 Country of ref document: HK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060504 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 38/20 20060101ALI20060427BHEP Ipc: A61K 38/19 20060101ALI20060427BHEP Ipc: A61K 38/18 20060101ALI20060427BHEP Ipc: A61K 38/09 20060101ALI20060427BHEP Ipc: A61K 38/08 20060101ALI20060427BHEP Ipc: A61K 35/28 20060101ALI20060427BHEP Ipc: A61K 35/14 20060101ALI20060427BHEP Ipc: A61P 31/00 20060101AFI20020711BHEP |
|
17Q | First examination report despatched |
Effective date: 20060808 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NORWOOD IMMUNOLOGY, LTD. |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: CHIDGEY, ANN Inventor name: BOYD, RICHARD, C/O DPT.OF PATHOLOGY & IMMUNOLOGY |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1061366 Country of ref document: HK |
|
18R | Application refused |
Effective date: 20100128 |